When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALPMF - FDA grants accelerated review for Seattle Genetics ADC for urothelial cancer
Astellas Pharma Inc
The FDA accepts under Priority Review status Seattle Genetics' (NASDAQ:SGEN) marketing application for antibody-drug conjugate enfortumab vedotin for patients with locally advanced or metastatic urothelial cancer who have received a PD-1/L1 inhibitor and who have received a platinum-containing chemotherapy in the neoadjuvant/adjuvant, locally advanced or metastatic setting.
More news on: Seattle Genetics, Inc., Astellas Pharma Inc., Astellas Pharma Inc., Healthcare stocks news,